Recent advancements in cardiac regeneration research have led to innovative therapies that aim to enhance the healing process after cardiac injury. Preclinical studies and early-phase clinical trials are exploring the safety and efficacy of various regenerative approaches. These may involve the transplantation of stem cells, the use of growth factors to stimulate tissue repair, or the development of bioengineered cardiac patches that can be implanted to replace damaged tissue. The ultimate goal is to develop interventions that not only repair the structural damage caused by heart diseases but also restore optimal cardiac function. While challenges and complexities remain, the potential for cardiac regeneration to transform the landscape of cardiovascular medicine is driving continued research and collaboration among scientists, clinicians, and experts in regenerative medicine.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain